FDA Weighs In on Actos Risks

March 25, 2012

The federal government’s Food and Drug Administration (FDA) recently announced that the public should be aware of the risks associated with extended use of Actos (pioglitazone). For thousands of American diabetes patients, Actos is an important pharmaceudical solution to their health problems. However, medical research cited by the FDA argues that Actos may do more harm than good.

 

An ongoing safety review suggests that increased risk of bladder cancer positively correlates with relatively large, cumulative exposure to pioglitazone. In short, beyond 12 months, Actos patients may see the early symptoms of bladder cancer.

 

Are you an Actos patient who has noticed unusual bladder-related symptoms like blood in your urine? If so, the time to act is now and the call to make is to the attorneys and dedicated professionals at Fears Nachawati. With years of experience, we can help you. For your free consultation, call us at 1.866.545.8364 or email mn@fnlawfirm.com

More Blog Posts

CONTACT US

Use the form below to send us a note, call us at 214.890.0711 or chat with us live. We are eager to help with all your legal needs. Please keep in mind that any unsolicited information sent through our website cannot be treated as confidential. Contacting us through this site does not create a representation relationship with Fears | Nachawati.

Inquiry Type

  • General
  • Personal Injury
  • Immigration
  • Bankruptcy
  • Drug Litigation
  • Family Law

Locations

With offices in Texas, Florida and Colorado and attorneys licensed in Texas, Florida, Colorado, Arkansas and Oklahoma, Fears | Nachawati is dedicated to attaining the best possible solutions for our clients’ business and personal needs. We strive to be professionals who are creative, empathetic and reliable.

All Areas Served

We Can Help

Contact Fears Nachawati today

Free Consulation

Live Chat (Online Now)